EGFR and EGFRvIII undergo stress- and EGFR kinase inhibitor-induced mitochondrial translocalization: A potential mechanism of EGFR-driven antagonism of apoptosis
<p>Abstract</p> <p>Background</p> <p>Epidermal growth factor receptor (EGFR) plays an essential role in normal development, tumorigenesis and malignant biology of human cancers, and is known to undergo intracellular trafficking to subcellular organelles. Although severa...
Main Authors: | Ali-Osman Francis, Zhu Hu, Cao Xinyu, Lo Hui-Wen |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-03-01
|
Series: | Molecular Cancer |
Online Access: | http://www.molecular-cancer.com/content/10/1/26 |
Similar Items
-
The natural history of EGFR and EGFRvIII in glioblastoma patients
by: Shi Weiming, et al.
Published: (2005-10-01) -
Current therapeutic advances targeting EGFR and EGFRvIII in glioblastoma
by: Emily ePadfield, et al.
Published: (2015-01-01) -
The biological and clinical significance of EGFR, EGFRvIII and IGF-IR in colorectal cancer
by: Cunningham, Matthew Paul
Published: (2005) -
EGFR and EGFRvIII Promote Angiogenesis and Cell Invasion in Glioblastoma: Combination Therapies for an Effective Treatment
by: Stefanie Keller, et al.
Published: (2017-06-01) -
Simultaneous detection of EGFR amplification and EGFRvIII variant using digital PCR-based method in glioblastoma
by: Maxime Fontanilles, et al.
Published: (2020-04-01)